Placental Inflammation in Pre-Eclampsia by Nod-Like Receptor Protein (NLRP)3 Inflammasome Activation in Trophoblasts

Placental Inflammation in Pre-Eclampsia by Nod-Like Receptor Protein (NLRP)3 Inflammasome Activation in Trophoblasts

Clinical and Experimental Immunology ORIGINAL ARTICLE doi:10.1111/cei.13130 Placental inflammation in pre-eclampsia by Nod-like receptor protein (NLRP)3 inflammasome activation in trophoblasts G. S. Stødle,*† G. B. Silva,*† Summary L. H. Tangera˚s,*† L. M. Gierman,* Pre-eclampsia is associated with increased levels of cholesterol and uric acid I. Nervik,‡ U. E. Dahlberg,† C. Sun,§ and an inflamed placenta expressing danger-sensing pattern recognition M. H. Aune,* L. C. V. Thomsen,*§¶ receptors (PRRs). Crystalline cholesterol and uric acid activate the PRR L. Bjørge§¶ and A.-C. Iversen * *Centre of Molecular Inflammation Research Nod-like receptor protein (NLRP)3 inflammasome to release interleukin (CEMIR), Department of Clinical and (IL)-1b and result in vigorous inflammation. We aimed to characterize Molecular Medicine, Norwegian University of crystal-induced NLRP3 activation in placental inflammation and examine its Science and Technology (NTNU), Trondheim, role in pre-eclampsia. We confirmed that serum total cholesterol and uric Norway, †Department of Gynecology and acid were elevated in pre-eclamptic compared to healthy pregnancies and Obstetrics, St Olav’s Hospital, Trondheim, correlated positively to high sensitivity C-reactive protein (hsCRP) and the Norway, ‡Cellular and Molecular Imaging Core pre-eclampsia marker soluble fms-like tyrosine kinase-1 (sFlt-1). The Facility (CMIC), Faculty of Medicine and NLRP3 inflammasome pathway components (NLRP3, caspase-1, IL-1b) and Health Science, NTNU, Trondheim, Norway, priming factors [complement component 5a (C5a) and terminal § Department of Gynecology and Obstetrics, complement complex (TCC)] were co-expressed by the syncytiotrophoblast Haukeland University Hospital, Bergen, layer which covers the placental surface and interacts with maternal blood. Norway, and ¶Department of Clinical Science, The expression of IL-1b and TCC was increased significantly and C5a- Centre for Cancer Biomarkers, University of Bergen, Bergen, Norway positive regions in the syncytiotrophoblast layer appeared more frequent in pre-eclamptic compared to normal pregnancies. In-vitro activation of placental explants and trophoblasts confirmed NLRP3 inflammasome Accepted for publication 19 March 2018 pathway functionality by complement-primed crystal-induced release of IL- Correspondence: A.-C. Iversen, Centre of Molecular Inflammation Research (CEMIR), 1b. This study confirms crystal-induced NLRP3 inflammasome activation Department of Clinical and Molecular located at the syncytiotrophoblast layer as a mechanism of placental Medicine, Norwegian University of Science inflammation and suggests contribution of enhanced NLRP3 activation to and Technology (NTNU), Olav Kyrres gt 10, the harmful placental inflammation in pre-eclampsia. NO-7491 Trondheim, Norway. Keywords: cholesterol, inflammation, NLRP3, placenta, pre-eclampsia E-mail: [email protected] Introduction stressed and inflamed organ not able to meet the increas- ing demands of the growing fetus. The cellular interplay Increased inflammation, marked by changes in cytokines and underlying inflammatory mechanisms in the pla- and C-reactive protein (CRP), is part of the physiological centa are only partially understood. The main predictive adaptation of a normal pregnancy [1,2]. Disturbance of this inflammatory state characterizes the development of marker for pre-eclampsia, soluble fms-like tyrosine pregnancy complications such as pre-eclampsia and fetal kinase-1 (sFlt-1), is derived mainly from placental troph- growth restriction (FGR), which are major causes of oblasts, and points to a central role for these specialized maternal and fetal morbidity and mortality [2–4]. Pre- fetal cells in the pre-eclampsia pathogenesis [6,7]. This eclampsia affects 2–8% of pregnancies and is associated role is particularly important for the cytotrophoblasts, with 12% of infants with FGR and approximately 20% of whichfusetoformamulti-nucleatedcelllayercalledthe preterm deliveries [5]. Pre-eclampsia often starts with syncytium that covers the fetal structures in the placenta local placental dysfunction and develops into a maternal and interacts directly with maternal blood. This is the disease identified by maternal hypertension and main maternal–fetal interaction site. Trophoblasts are proteinuria. Insufficient placental development creates a immune-competent cells [8] and identification of their VC 2018 British Society for Immunology, Clinical and Experimental Immunology, 00: 00–00 1 G. S. Stødle et al. inflammatory properties is required to understand the Materials and methods placental inflammation underlying the development of pre-eclampsia. Study population An inflammatory response can be initiated when danger This study used placental and maternal serum samples signals from pathogens or damaged tissue are recognized from two collections approved by the Norwegian Regional by pattern recognition receptors (PRRs), and a cell’s poten- Committee for Medical and Health Research Ethics; tial for inflammatory involvement is defined by its PRR approval number 2012/1040 and 2009/03. All participants repertoire. Endogenous danger signals initiate and main- signed informed consent. tain inflammatory responses through activation of PRRs Third-trimester placental biopsies from healthy (n 5 13) such as nucleotide-binding domain leucine-rich repeat and pre-eclamptic singleton pregnancies with (n 5 12) or containing (NLR) proteins [9]. Members of the NLR without (n 5 11) FGR, and maternal serum samples from protein family form intracellular multi-protein structures healthy (n 5 43) and pre-eclamptic (n 5 34) pregnancies, called inflammasomes [10], which are involved in inflam- were analysed. Serum samples from non-pregnant women in matory diseases such as atherosclerosis, gout and diabetes the follicular phase of the menstrual cycle (n 5 28) were also mellitus [11]. Activation of the Nod-like receptor protein included. Pregnant women were diagnosed with pre- (NLRP)3 inflammasome by a wide variety of danger sig- eclampsia when developing persistent hypertension (blood nals, including crystalline forms of cholesterol and uric pressure 140/90 mmHg) plus proteinuria ( 0Á3g/24hor acid [11–13], leads to activation of caspase-1 and cleavage reproducible 11 by dipstick) after 20 weeks of gestation of pro-interleukin (IL)-1b to its biologically active form [40]. FGR was established by serial ultrasound measurements [10]. Mature IL-1b has potent proinflammatory character- or diagnosed if neonates had birth weight < 5th percentile, istics, and plays an important role in atherosclerosis devel- according to Norwegian reference curves [41]. Healthy nor- opment through NLRP3 activation [13,14]. Complement motensive pregnant women with no previous pre-eclampsia factors, cytokines or other danger signals are needed to or FGR were included as controls. Maternal venous blood was induce a priming signal to render cells responsive to collected prior to delivery and placentas obtained directly after NLRP3 activation [15]. The complement system is involved delivery by caesarean section without labour. Serum aliquots in the pathology of several inflammatory diseases [16,17], were stored at 2808C, and placental biopsies were cut tangen- and activation involves generation of the potent anaphyla- tially from the central part of the maternal side before fixation toxin complement component 5a (C5a) and the terminal in 10% neutral-buffered formalin and paraffin embedding. complement complex (TCC). Combined C5a and tumour First-trimester placental tissue was collected from surgi- necrosis factor (TNF)-a exposure is a known priming sig- cal elective abortions at gestational age 7–12 weeks. Placen- nal for cholesterol and uric acid crystal-induced NLRP3 tal samples (n 5 10) were snap-frozen and stored at 2808C activation [18,19]. until fixation and paraffin-embedding. A group of third- Detailed characterization of placental expression and trimester placentas (n 5 10) were collected from healthy activation of PRRs is needed to reveal the underlying women delivering by caesarean section for immediate isola- mechanisms and cellular contributions to placental inflam- tion of chorionic villous explants. mation in pre-eclampsia [20]. PRR activation in pre- eclampsia may be induced by factors derived from mater- Serum measurements nal serum and/or within the stressed placental tissue. It has Total cholesterol and uric acid were measured in maternal been reported that maternal serum levels of cholesterol and serum. Esterified cholesterol was modified enzymatically by uric acid are elevated in pre-eclampsia and FGR [21–28], cholesterol esterase and cholesterol oxidase. The resulting that cholesterol is accumulated in pre-eclamptic placentas hydrogen peroxide reacted with 4-aminoantipyrine and [29] and that uric acid crystals activate the NLRP3 inflam- phenol in presence of peroxidase and the coloured product masome in human placentas [30]. Trophoblast NLRP3 was measured at 505 nm. Uric acid was oxidized by uricase, activation has been assigned a role in pre-eclampsia devel- and the resulting hydrogen peroxide reacted with N-ethyl- opment [31–34]. Raised serum and placental levels of N-(2-hydroxy-3-sulphopropyl)-3-methylalanine and 4- IL-1b and excessive complement activation in women aminopyrine in the presence of peroxidase, and the col- with pre-eclampsia [3,28,31,35–39] further indicates a role oured product was measured at 545 nm. High-sensitivity for placental NLRP3 inflammasome involvement

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    11 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us